Scientific reports

Analytical chemistry

hematological oncology

European journal of haematology

Leukemia & lymphoma

hawai'i journal of health & social welfare

cold spring harbor protocols

[1] Low incidence of post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation in patients with lymphoma treated with rituximab.

[2] Association of CD204 macrophages with poor outcomes of malignant lymphomas not in remission treated by allogeneic HCT.

[3] Education and End-of-Life Options: Hawaii's Our Care, Our Choice Act.

[4] Medical School Hotline: Governor Ige's Remarks - John A. Burns School of Medicine University of Hawai'i at Mānoa, Convocation Ceremony Keynote Address, Sunday, May 12, 2019.

[5] Retreatment with brentuximab vedotin in patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large-cell lymphoma: a multicenter retrospective study.

[6] Rapid and efficient high-performance liquid chromatography analysis of N-nitrosodimethylamine impurity in valsartan drug substance and its products.

[7] Improved Atomic Force Microscopy Stiffness Measurements of Nanoscale Liposomes by Cantilever Tip Shape Evaluation.

[8] Erratum: Skin Grafting in : A Technique for Assessing Development and Immunological Disparity.

[9] interleukin-6 in allogeneic stem cell transplantation: its possible importance for immunoregulation and as a therapeutic target

[10] the role of regulatory t cells in the biology of graft versus host disease

[11] Allogeneic stem cell transplantation in patients with myelofibrosis harboring the MPL mutation.

[12] Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: A consensus process by an EBMT/ELN international working group

[13] The impact of concomitant cytogenetic abnormalities on acute myeloid leukemia with monosomy 7 or deletion 7q after HLA-matched allogeneic stem cell transplantation.

[14] Low incidence of post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation in patients with lymphoma treated with rituximab.

[15] Alectinib, an anaplastic lymphoma kinase (ALK) inhibitor, as a bridge to allogeneic stem cell transplantation in a patient with ALK-positive anaplastic large-cell lymphoma refractory to chemotherapy and brentuximab vedotin.

[16] Pure red cell aplasia after ABO-incompatible allogeneic stem cell transplantation in severe aplastic anemia with response to steroids: a case report and literature review

[17] the role of allogeneic stem cell transplantation in relapsed/refractory hodgkin's lymphoma patients

[18] interleukin-6 in allogeneic stem cell transplantation: its possible importance for immunoregulation and as a therapeutic target

[19] current role of autologous and allogeneic stem cell transplantation for relapsed and refractory hodgkin lymphoma

[20] preconditioning serum levels of endothelial cell-derived molecules and the risk of posttransplant complications in patients treated with allogeneic stem cell transplantation

[21] peripheral blood wt1 expression predicts relapse in aml patients undergoing allogeneic stem cell transplantation

[22] efficacy and pharmacologic data of second-generation tyrosine kinase inhibitor nilotinib in bcr-abl-positive leukemia patients with central nervous system relapse after allogeneic stem cell transplantation

[23] allogeneic stem cell transplantation for thalassemia major in india

[24] Quantitative analysis of chimerism after allogeneic stem cell transplantation by real-time polymerase chain reaction with single nucleotide polymorphisms, standard tandem repeats, and Y-chromosome-specific sequences.

[25] Early Detection of Toxoplasma Infection by Molecular Monitoring of Toxoplasma gondii in Peripheral Blood Samples after Allogeneic Stem Cell Transplantation

[26] Immune Reconstitution Following Allogeneic Stem Cell Transplantation in HIV infected Individuals: Years of Living Danger-ously